Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia

E. Engidawork, F. Loidl, Y. Chen, C. Kohlhauser, S. Stoeckler, E. Dell'Anna, B. Lubec, G. Lubec, M. Goiny, J. Gross, K. Andersson, M. Herrera-Marschitz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This study investigated the influence of temperature or glutamate antagonism on the immediate outcome of perinatal asphyxia. Perinatal asphyxia was produced by water immersion of fetus-containing uterus horns removed by cesarean section from ready to deliver rats. The uterus horns were kept in a water bath for different time periods, before the pups were delivered and stimulated to breathe. After delivery, the pups were assessed for behavior and for systemic glutamate, aspartate, lactate and pyruvate levels measured with in vivo microdialysis, or ex vivo for energy-rich phosphates, including adenosine triphosphate (ATP), in brain, heart and kidney. In a series of experiments, asphyxia was initiated in a water bath at 37°C, before the pup-containing uterus horns were moved for different time intervals to a 15°C bath. In another series of experiments, the mothers were treated with N-methyl-D-aspartate (NMDA) antagonist, dizocilpine (MK-801), or α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl benzo(f) quinoxaline (NBQX) 1 h before hysterectomy and asphyxia at 37°C. The rate of survival rapidly decreased following exposure to more than 16 min of asphyxia, and no survival could be observed after 22 (min of asphyxia. An LD50 was estimated to occur at ∼19 min of asphyxia. The outcome was paralleled by a decrease in ATP in kidney, followed by a decrease in heart and brain. A maximal decrease in ATP was observed after 20 min of asphyxia in all tissues. Systemic microdialysis revealed that glutamate, aspartate and pyruvate levels were increased with a peak after 5 min of asphyxia. In contrast, lactate levels increased along with the length of the insult. Survival was increased when the pup-containing uterus horns were moved from a 37°C to a 15°C bath, at 15 min of asphyxia (the LD50 was thus increased to 30 min). If the shift occurred at 10 or 5 min of asphyxia, the LD50 increased to 80 or 110 min, respectively. The effect of glutamate antagonism was minor compared to hypothermia; the (best effect an increase in the LD50 to ∼22 min) was observed after combining AMPA and NMDA antagonists.

Original languageEnglish
Pages (from-to)375-383
Number of pages9
JournalExperimental Brain Research
Volume138
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Asphyxia
Hypothermia
Glutamic Acid
Lethal Dose 50
Horns
Baths
Uterus
Therapeutics
Dizocilpine Maleate
Adenosine Triphosphate
Microdialysis
N-Methylaspartate
Pyruvic Acid
Aspartic Acid
Water
Lactic Acid
Kidney
Brain
Immersion
Hysterectomy

Keywords

  • Asphyxia
  • Glutamate antagonism
  • Hypothermia
  • Microdialysis
  • Neonatal
  • Rat

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. / Engidawork, E.; Loidl, F.; Chen, Y.; Kohlhauser, C.; Stoeckler, S.; Dell'Anna, E.; Lubec, B.; Lubec, G.; Goiny, M.; Gross, J.; Andersson, K.; Herrera-Marschitz, M.

In: Experimental Brain Research, Vol. 138, No. 3, 2001, p. 375-383.

Research output: Contribution to journalArticle

Engidawork, E, Loidl, F, Chen, Y, Kohlhauser, C, Stoeckler, S, Dell'Anna, E, Lubec, B, Lubec, G, Goiny, M, Gross, J, Andersson, K & Herrera-Marschitz, M 2001, 'Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia', Experimental Brain Research, vol. 138, no. 3, pp. 375-383. https://doi.org/10.1007/s002210100710
Engidawork, E. ; Loidl, F. ; Chen, Y. ; Kohlhauser, C. ; Stoeckler, S. ; Dell'Anna, E. ; Lubec, B. ; Lubec, G. ; Goiny, M. ; Gross, J. ; Andersson, K. ; Herrera-Marschitz, M. / Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. In: Experimental Brain Research. 2001 ; Vol. 138, No. 3. pp. 375-383.
@article{37a3592b99f54ee2931661dc5e2bfda0,
title = "Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia",
abstract = "This study investigated the influence of temperature or glutamate antagonism on the immediate outcome of perinatal asphyxia. Perinatal asphyxia was produced by water immersion of fetus-containing uterus horns removed by cesarean section from ready to deliver rats. The uterus horns were kept in a water bath for different time periods, before the pups were delivered and stimulated to breathe. After delivery, the pups were assessed for behavior and for systemic glutamate, aspartate, lactate and pyruvate levels measured with in vivo microdialysis, or ex vivo for energy-rich phosphates, including adenosine triphosphate (ATP), in brain, heart and kidney. In a series of experiments, asphyxia was initiated in a water bath at 37°C, before the pup-containing uterus horns were moved for different time intervals to a 15°C bath. In another series of experiments, the mothers were treated with N-methyl-D-aspartate (NMDA) antagonist, dizocilpine (MK-801), or α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl benzo(f) quinoxaline (NBQX) 1 h before hysterectomy and asphyxia at 37°C. The rate of survival rapidly decreased following exposure to more than 16 min of asphyxia, and no survival could be observed after 22 (min of asphyxia. An LD50 was estimated to occur at ∼19 min of asphyxia. The outcome was paralleled by a decrease in ATP in kidney, followed by a decrease in heart and brain. A maximal decrease in ATP was observed after 20 min of asphyxia in all tissues. Systemic microdialysis revealed that glutamate, aspartate and pyruvate levels were increased with a peak after 5 min of asphyxia. In contrast, lactate levels increased along with the length of the insult. Survival was increased when the pup-containing uterus horns were moved from a 37°C to a 15°C bath, at 15 min of asphyxia (the LD50 was thus increased to 30 min). If the shift occurred at 10 or 5 min of asphyxia, the LD50 increased to 80 or 110 min, respectively. The effect of glutamate antagonism was minor compared to hypothermia; the (best effect an increase in the LD50 to ∼22 min) was observed after combining AMPA and NMDA antagonists.",
keywords = "Asphyxia, Glutamate antagonism, Hypothermia, Microdialysis, Neonatal, Rat",
author = "E. Engidawork and F. Loidl and Y. Chen and C. Kohlhauser and S. Stoeckler and E. Dell'Anna and B. Lubec and G. Lubec and M. Goiny and J. Gross and K. Andersson and M. Herrera-Marschitz",
year = "2001",
doi = "10.1007/s002210100710",
language = "English",
volume = "138",
pages = "375--383",
journal = "Experimental Brain Research",
issn = "0014-4819",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia

AU - Engidawork, E.

AU - Loidl, F.

AU - Chen, Y.

AU - Kohlhauser, C.

AU - Stoeckler, S.

AU - Dell'Anna, E.

AU - Lubec, B.

AU - Lubec, G.

AU - Goiny, M.

AU - Gross, J.

AU - Andersson, K.

AU - Herrera-Marschitz, M.

PY - 2001

Y1 - 2001

N2 - This study investigated the influence of temperature or glutamate antagonism on the immediate outcome of perinatal asphyxia. Perinatal asphyxia was produced by water immersion of fetus-containing uterus horns removed by cesarean section from ready to deliver rats. The uterus horns were kept in a water bath for different time periods, before the pups were delivered and stimulated to breathe. After delivery, the pups were assessed for behavior and for systemic glutamate, aspartate, lactate and pyruvate levels measured with in vivo microdialysis, or ex vivo for energy-rich phosphates, including adenosine triphosphate (ATP), in brain, heart and kidney. In a series of experiments, asphyxia was initiated in a water bath at 37°C, before the pup-containing uterus horns were moved for different time intervals to a 15°C bath. In another series of experiments, the mothers were treated with N-methyl-D-aspartate (NMDA) antagonist, dizocilpine (MK-801), or α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl benzo(f) quinoxaline (NBQX) 1 h before hysterectomy and asphyxia at 37°C. The rate of survival rapidly decreased following exposure to more than 16 min of asphyxia, and no survival could be observed after 22 (min of asphyxia. An LD50 was estimated to occur at ∼19 min of asphyxia. The outcome was paralleled by a decrease in ATP in kidney, followed by a decrease in heart and brain. A maximal decrease in ATP was observed after 20 min of asphyxia in all tissues. Systemic microdialysis revealed that glutamate, aspartate and pyruvate levels were increased with a peak after 5 min of asphyxia. In contrast, lactate levels increased along with the length of the insult. Survival was increased when the pup-containing uterus horns were moved from a 37°C to a 15°C bath, at 15 min of asphyxia (the LD50 was thus increased to 30 min). If the shift occurred at 10 or 5 min of asphyxia, the LD50 increased to 80 or 110 min, respectively. The effect of glutamate antagonism was minor compared to hypothermia; the (best effect an increase in the LD50 to ∼22 min) was observed after combining AMPA and NMDA antagonists.

AB - This study investigated the influence of temperature or glutamate antagonism on the immediate outcome of perinatal asphyxia. Perinatal asphyxia was produced by water immersion of fetus-containing uterus horns removed by cesarean section from ready to deliver rats. The uterus horns were kept in a water bath for different time periods, before the pups were delivered and stimulated to breathe. After delivery, the pups were assessed for behavior and for systemic glutamate, aspartate, lactate and pyruvate levels measured with in vivo microdialysis, or ex vivo for energy-rich phosphates, including adenosine triphosphate (ATP), in brain, heart and kidney. In a series of experiments, asphyxia was initiated in a water bath at 37°C, before the pup-containing uterus horns were moved for different time intervals to a 15°C bath. In another series of experiments, the mothers were treated with N-methyl-D-aspartate (NMDA) antagonist, dizocilpine (MK-801), or α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl benzo(f) quinoxaline (NBQX) 1 h before hysterectomy and asphyxia at 37°C. The rate of survival rapidly decreased following exposure to more than 16 min of asphyxia, and no survival could be observed after 22 (min of asphyxia. An LD50 was estimated to occur at ∼19 min of asphyxia. The outcome was paralleled by a decrease in ATP in kidney, followed by a decrease in heart and brain. A maximal decrease in ATP was observed after 20 min of asphyxia in all tissues. Systemic microdialysis revealed that glutamate, aspartate and pyruvate levels were increased with a peak after 5 min of asphyxia. In contrast, lactate levels increased along with the length of the insult. Survival was increased when the pup-containing uterus horns were moved from a 37°C to a 15°C bath, at 15 min of asphyxia (the LD50 was thus increased to 30 min). If the shift occurred at 10 or 5 min of asphyxia, the LD50 increased to 80 or 110 min, respectively. The effect of glutamate antagonism was minor compared to hypothermia; the (best effect an increase in the LD50 to ∼22 min) was observed after combining AMPA and NMDA antagonists.

KW - Asphyxia

KW - Glutamate antagonism

KW - Hypothermia

KW - Microdialysis

KW - Neonatal

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0035000839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035000839&partnerID=8YFLogxK

U2 - 10.1007/s002210100710

DO - 10.1007/s002210100710

M3 - Article

C2 - 11460776

AN - SCOPUS:0035000839

VL - 138

SP - 375

EP - 383

JO - Experimental Brain Research

JF - Experimental Brain Research

SN - 0014-4819

IS - 3

ER -